골수흡인물 농축액 및 기질유래연골형성 수술 이후 관찰된 거골의 골연골병변의 골유합: 증례 보고

Traditionally, arthroscopic microfracture and autologous osteochondral autograft transplantation have been the primary surgical treatments for osteochondral lesions of the talus. On the other hand, recent advancements have introduced alternative approaches, such as autologous chondrocyte transplanta...

Full description

Saved in:
Bibliographic Details
Published in대한족부족관절학회지 Vol. 27; no. 4; pp. 148 - 153
Main Authors 송태훈, 서진수, 최준영, Tae Hun Song, Jin Soo Suh, Jun Young Choi
Format Journal Article
LanguageKorean
Published 대한족부족관절학회 01.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Traditionally, arthroscopic microfracture and autologous osteochondral autograft transplantation have been the primary surgical treatments for osteochondral lesions of the talus. On the other hand, recent advancements have introduced alternative approaches, such as autologous chondrocyte transplantation, matrix-derived autologous chondrocyte transplantation, intra-articular injection of concentrated bone marrow aspirate concentrate, and the use of fibrin glue to address chondral defects. Furthermore, some studies have explored a combination of bone marrow aspirate and matrix-derived chondrogenesis. In light of these developments, this report presents a case study of a young male patient in his early twenties with a relatively large osteochondral lesion exceeding 1.5 cm2 on the medial talar dome. Instead of removing the osteochondral lesion, a surgical approach was employed to retain the lesion while addressing the unstable cartilage in the affected area. This approach involved a combination of bone marrow aspirate concentrate and matrix-derived chondrogenesis. The treatment yielded favorable clinical outcomes and ultimately successfully induced the bony union of osteochondral lesions. This paper reports the author's experience with this innovative approach with a review of the relevant literature.
Bibliography:KISTI1.1003/JNL.JAKO202305857678864
ISSN:1738-3757
2288-8551
DOI:10.14193/jkfas.2023.27.4.148